Ex Parte Lepine - Page 14



         Appeal No. 2005-1949                                                       
         Application No. 09/829,168                                                 

         Boesch, 617 F.2d 272, 276, 205 USPQ 215, 218-19 (CCPA 1980); In            
         re Aller, 220 F.2d 454, 456, 105 USPQ 233, 235 (CCPA 1955).                
         Hence, we determine that the limited range in Meyer renders                
         obvious appellant’s recited ratio in claim 1.                              
              As a consequence, we agree with the examiner that (1) the             
         reference discloses each claim limitation from claims 1 and 9,             
         and (2) if there is any difference, the difference is minor and            
         the recited ratio is a) obvious over the range disclosed in Meyer          
         and b) simple optimization of a result-effective variable.                 
              We therefore affirm this rejection as it relates to                   
         obviousness.                                                               
              F. The Rejection of Claims 3-5, 11 and 12 Under 35 U.S.C.             
         §103(a).                                                                   
              Claims 3-5, 11, and 12 stand rejected under 35 U.S.C.                 
         §103(a) as being unpatentable as obvious over the disclosure of            
         Meyer.                                                                     
              Claim 3 reads as follows:                                             
              3.  The method of claim 1, in which said composition                  
         comprises about 38% protein.                                               
              Claim 4 reads as follows:                                             
              4.  The method of claim 1, in which said composition                  
         comprises about 28% fat.                                                   

                                         14                                         




Page:  Previous  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  Next 

Last modified: November 3, 2007